Morphologically and immunophenotypically, the number of B-lymphocyte progenitor cells, so-called hematogones increases after chemotherapy and allogeneic stem cell transplantions. It is thought that hematogones can be used as a prognostic marker in these patients. It is aimed to determine the prognostic significance and factors affecting the development of hematogones, which can be seen after autologous stem cell transplantation in multiple myeloma (MM) patients.

中文翻译：

---

多发性骨髓瘤患者自体干细胞移植后血细胞素存在的预后意义

在形态学和免疫表型上，B 淋巴细胞祖细胞（所谓的血细胞）的数量在化疗和同种异体干细胞移植后增加。认为血细胞激素可用作这些患者的预后标志物。旨在确定多发性骨髓瘤 (MM) 患者自体干细胞移植后的预后意义和影响血细胞生长的因素。